Also, the first study using massively parallel sequencing of 38 MM genomes could confirm previously described mutations in MM, but it also identified novel genetic lesions, i.e. BRAF mutations, in a small fraction of MM patients that may indeed have implications for therapy (29). The gene discussed is BRAF; the disease is Miyoshi myopathy.